Pembrolizumab, Ixazomib Citrate, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma
Clinical trial NCT03506360 · COMPLETED
Trial details
- NCT number
- NCT03506360
- Sponsor
- Mayo Clinic
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-19
- Primary completion
- 2019-11-14
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.